These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21167131)

  • 1. Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation.
    Shahlaei M; Madadkar-Sobhani A; Mahnam K; Fassihi A; Saghaie L; Mansourian M
    Biochim Biophys Acta; 2011 Mar; 1808(3):802-17. PubMed ID: 21167131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.
    Gadhe CG; Kothandan G; Cho SJ
    J Biomol Struct Dyn; 2013; 31(11):1251-76. PubMed ID: 23153179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal of a new binding orientation for non-peptide AT1 antagonists: homology modeling, docking and three-dimensional quantitative structure-activity relationship analysis.
    Tuccinardi T; Calderone V; Rapposelli S; Martinelli A
    J Med Chem; 2006 Jul; 49(14):4305-16. PubMed ID: 16821790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity.
    Paterlini MG
    Biophys J; 2002 Dec; 83(6):3012-31. PubMed ID: 12496074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.
    Kothandan G; Gadhe CG; Cho SJ
    PLoS One; 2012; 7(3):e32864. PubMed ID: 22479344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking.
    Arumugam K; Crouzy S; Chevigne A; Seguin-Devaux C; Schmit JC
    J Biomol Struct Dyn; 2014; 32(8):1274-89. PubMed ID: 23869548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring a model of a chemokine receptor/ligand complex in an explicit membrane environment by molecular dynamics simulation: the human CCR1 receptor.
    Shahlaei M; Madadkar-Sobhani A; Fassihi A; Saghaie L
    J Chem Inf Model; 2011 Oct; 51(10):2717-30. PubMed ID: 21910472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
    Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study of the binding pocket.
    Castonguay LA; Weng Y; Adolfsen W; Di Salvo J; Kilburn R; Caldwell CG; Daugherty BL; Finke PE; Hale JJ; Lynch CL; Mills SG; MacCoss M; Springer MS; DeMartino JA
    Biochemistry; 2003 Feb; 42(6):1544-50. PubMed ID: 12578367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.
    Bera I; Laskar A; Ghoshal N
    J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models.
    Li G; Haney KM; Kellogg GE; Zhang Y
    J Chem Inf Model; 2009 Jan; 49(1):120-32. PubMed ID: 19166361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
    Patny A; Desai PV; Avery MA
    Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis.
    Wang J; Shu M; Wang Y; Hu Y; Wang Y; Luo Y; Lin Z
    Mol Biosyst; 2016 Oct; 12(11):3396-3406. PubMed ID: 27714030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Screening of CCR5 Inhibitors as Potential Entry Inhibitor Microbicides Using 3D-QSAR Studies, Docking and Molecular Dynamics Simulation.
    Ramachandran R; Aathi M; Ruban DD; Piramanyagam S
    Curr HIV Res; 2017; 15(4):234-244. PubMed ID: 28059045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.
    Springael JY; de Poorter C; Deupi X; Van Durme J; Pardo L; Parmentier M
    Cell Signal; 2007 Jul; 19(7):1446-56. PubMed ID: 17320349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of HIV-1 coreceptor CCR5 and exploring of conformational space of its extracellular domain in molecular dynamics simulation.
    Efremov RG; Legret F; Vergoten G; Capron A; Bahr GM; Arseniev AS
    J Biomol Struct Dyn; 1998 Aug; 16(1):77-90. PubMed ID: 9745897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor.
    Singh R; Sobhia ME
    J Biomol Struct Dyn; 2013; 31(7):694-715. PubMed ID: 22909007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.